On March 21, 2024, MAIA Biotechnology, Inc. closed the transaction. The transaction included participation from 19 investors including returning investor Stan V. Smith for 170,940 shares.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.15 USD | -16.22% | -27.98% | +168.38% |
04/06 | Maia Biotechnology Reveals New Clinical Data Showing Thio?s Strong Efficacy in Non-Small Cell Lung Cancer | CI |
21/05 | MAIA Biotechnology, Inc. announced a financing transaction | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+168.38% | 8.21Cr | |
+52.08% | 5.57TCr | |
+41.08% | 3.99TCr | |
-5.25% | 3.96TCr | |
-5.56% | 2.82TCr | |
+16.42% | 2.63TCr | |
-20.86% | 1.89TCr | |
+33.42% | 1.22TCr | |
+26.73% | 1.21TCr | |
+2.51% | 1.21TCr |
- Stock Market
- Equities
- MAIA Stock
- News MAIA Biotechnology, Inc.
- MAIA Biotechnology, Inc. announced that it has received $2.920692 million in funding